Global private equity PE firm KKR has bought majority ownership of India’s cancer care specialist Healthcare Global Enterprises from PE firm CVC, as regional deals continue to ramp up in this space.
As part of the transaction, KKR's Asia Fund IV will acquire up to 54% of equity in HCG from CVC Asia V at a purchase price of Rs445 per share $4.62, and a total value of $400 million, according to a media release.
Pursuant to the Securities and Exchange Board of India’s SEBI Takeover Regulations, an open offer will be conducted by KKR to purchase additional equity shares in HCG...
¬ Haymarket Media Limited. All rights reserved.
